ADMA Biologics, Inc

(NASDAQ:ADMA)

Latest On ADMA Biologics, Inc (ADMA):

Date/Time Type Description Signal Details
2023-05-11 01:31 ESTNewsADMA Biologics GAAP EPS of -$0.03 beats by $0.01, revenue of $57M beats by $3.59MN/A
2023-05-11 01:30 ESTNewsADMA Biologics, Inc. (ADMA) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 23:31 ESTNewsADMA Biologics Q1 2023 Earnings PreviewN/A
2023-03-30 00:16 ESTNewsADMA Biologics: Growth Trends Pointing To ProfitabilityN/A
2023-03-24 06:16 ESTNewsADMA Biologics GAAP EPS of -$0.06 beats by $0.01, revenue of $49.95M beats by $1.88MN/A
2023-03-24 06:16 ESTNewsADMA Biologics expects first-time positive EBITDA by second half of yearN/A
2023-03-24 06:15 ESTNewsADMA Biologics, Inc. (ADMA) Q4 2022 Earnings Call TranscriptN/A
2023-03-22 23:00 ESTNewsADMA Biologics Q4 2022 Earnings PreviewN/A
2023-02-08 18:02 ESTNewsADMA Biocenters receives FDA approval for eighth plasma collection centerN/A
2023-01-17 17:02 ESTNewsADMA Biologics gains as guidance exceeds consensusN/A
2023-01-15 06:00 ESTNewsADMA Biologics: FY22 Numbers Key Inflection PointN/A
2022-12-13 19:01 ESTNewsAdma gets FDA approval for room temperature storage of Asceniv, BivigamN/A
2022-12-08 03:17 ESTNewsADMA Biologics stock dips after pricing ~$60M share offeringN/A
2022-12-07 07:16 ESTNewsADMA Biologics down 7% following stock offeringN/A
2022-11-11 05:31 ESTNewsADMA Biologics hits 52-week high after strong Q3 beatN/A
2022-11-09 19:31 ESTNewsADMA Biologics GAAP EPS of -$0.08 in-line, revenue of $41.09M beats by $6.61MN/A
2022-11-09 19:30 ESTNewsADMA Biologics, Inc. (ADMA) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 01:31 ESTNewsADMA Biologics Q3 2022 Earnings PreviewN/A
2022-10-31 13:46 ESTNewsAdma stock rises on FDA approval of North Carolina-based plasma collection centerN/A
2022-10-24 18:01 ESTNewsAdma Biologics: Understanding The Risks Of Blood Plasma CollectionN/A
2022-08-22 16:50 ESTNewsADMA Biologics: Strong Growth Is Clearing The Path To ProfitabilityN/A
2022-08-11 22:17 ESTNewsADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 22:16 ESTNewsAdma stock rises 10% after Q2 revenue nearly doubles, net loss narrowsN/A
2022-08-11 05:31 ESTNewsADMA Biologics GAAP EPS of -$0.07, revenue of $33.9MN/A
2022-08-11 05:30 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 17:45 ESTNewsADMA Biologics Q2 2022 Earnings PreviewN/A
2022-06-27 23:02 ESTNewsADMA's 6th plasma collection facility gets FDA approvalN/A
2022-06-21 22:02 ESTNewsADMA biologics to enter Russell 2000 indexN/A
2022-05-13 06:31 ESTNewsADMA Biologics: A Path To Profits Looks ClearN/A
2022-05-12 11:47 ESTNewsADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-11 18:00 ESTNewsADMA Biologics GAAP EPS of -$0.13 misses by $0.04, revenue of $29.1M beats by $0.95MN/A
2022-05-11 18:00 ESTNewsADMA Biologics up 4% after increasing 2022 revenue guidanceN/A
2022-05-10 22:45 ESTNewsADMA Biologics Q1 2022 Earnings PreviewN/A
2022-04-19 02:16 ESTNewsADMA: Pertinent UpdatesN/A
2022-04-04 13:21 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-29 21:17 ESTNewsADMA Biologics' 2021 Numbers Showed Continued Strong ExecutionN/A
2022-03-25 12:19 ESTNewsADMA Biologics GAAP EPS of -$0.09 beats by $0.01, revenue of $26.38M beats by $4.61MN/A
2022-03-25 12:19 ESTNewsADMA Biologics up in after-hours trading following quarterly top and bottom line beatsN/A
2022-03-25 12:18 ESTNewsADMA Biologics gets FDA approval to extend shelf life of Asceniv, BivigamN/A
2022-03-24 02:33 ESTNewsADMA Biologics Q4 2021 Earnings PreviewN/A
2022-02-10 22:16 ESTNewsAdma Biologics activist said to support strategic reviewN/A
2022-01-19 08:15 ESTNewsADMA biologics expects record preliminary 4Q and FY21 revenues to be above the consensusN/A
2022-01-18 16:46 ESTNewsADMA Biologics wins FDA nod for its fourth plasma collection centerN/A
2022-01-18 16:46 ESTNewsADMA Biologics: 2021 Was ToughN/A
2021-12-28 22:16 ESTNewsFDA updates EUA for COVID convalescent plasma limiting use to certain patientsN/A
2021-12-09 15:17 ESTNewsADMA Biologics secures new European patent related to S. pneumonia infectionsN/A
2021-11-20 23:16 ESTNewsADMA Biologics: Turning A CornerN/A
2021-11-11 20:31 ESTNewsADMA Biologics raised to Strong Buy at Raymond James citing financial momentumN/A
2021-11-11 00:15 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 01:31 ESTNewsADMA Biologics Q3 2021 Earnings PreviewN/A

About ADMA Biologics, Inc (ADMA):

ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.

See Advanced Chart

General

  • Name ADMA Biologics, Inc
  • Symbol ADMA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 313
  • Fiscal Year EndDecember
  • IPO Date2013-10-17
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.admabiologics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 5.32
  • Price/Book (Most Recent Quarter) 3.7
  • Enterprise Value Revenue 7.55
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.17
  • Profit Margin -166%
  • Operating Margin -138%
  • Return on Assets -21%
  • Return on Equity -124%
  • Revenue 40.3 million
  • Earnings Per Share -$1.24
  • Revenue Per Share $0.53
  • Gross Profit -10155155
  • Quarterly Earnings Growth 42.3%
View More

Highlights

  • Market Capitalization 195.71 million
  • EBITDA -52103768
  • Analyst Target Price $8.83
  • Book Value Per Share $0.80
View More

Share Statistics

  • Shares Outstanding 94.55 million
  • Shares Float 76.07 million
  • % Held by Insiders 213%
  • % Held by Institutions 54.51%
  • Shares Short 8.18 million
  • Shares Short Prior Month 8.75 million
  • Short Ratio 1.91
  • Short % of Float 12%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • Beta 1.7
  • 52 Week High $4.2
  • 52 Week Low $1.73
  • 50 Day Moving Average 2.42
  • 200 Day Moving Average 2.23
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

ADMA Biologics, Inc (ADMA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ADMA Biologics, Inc (ADMA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$N/A-$0.19-$0.204.04%
2020-06-302020-08-05$N/A-$0.23-$0.16-42.24%
2020-03-312020-05-06$N/A-$0.26-$0.11-128.07%
2019-12-312020-03-12$12.04 million-$0.18-$0.18-0.95%
2019-09-302019-11-06$7.22 million-$0.19-$0.2315.56%
2019-06-302019-08-08$6.56 million-$0.25-$0.2914.65%
2019-03-312019-05-08$3.53 million-$0.28-$0.3211.39%
2018-12-312019-03-13$4.06 million-$0.39-$0.33-17.15%
2018-09-302018-11-08$4.23 million-$0.33-$0.31-6.45%
2018-06-302018-08-10$4.66 million-$0.35-$0.31-11.86%
2018-03-312018-05-14$4.04 million-$0.39-$0.31-26.83%
2017-12-312018-03-05$12 million-$0.24-$0.3938.46%
2017-09-302017-11-03$4.73 million-$0.59-$0.50-18.59%
2017-06-302017-08-11$3.4 million-$0.55-$0.30-84.87%
2017-03-312017-05-12$2.63 million-$0.51-$0.28-80.53%
2016-12-312017-02-24$3.33 million-$0.34-$0.32-5.59%
2016-09-302016-11-10$2.94 million-$0.34-$0.4117.87%
2016-06-302016-08-12$2.27 million-$0.50-$0.38-30.89%
2016-03-312016-05-13$2.12 million-$0.43-$0.442.82%
2015-12-312016-03-23$2.51 million-$0.44-$0.452.22%
2015-09-302015-11-10$1.85 million-$0.48-$0.39-23.08%
2015-06-302015-08-11$1.31 million-$0.44-$0.35-25.71%
2015-03-312015-05-12$1.5 million-$0.37-$0.382.63%
2014-12-312015-03-09$1.49 million-$0.38-$0.380%
2014-09-302014-11-10$1.37 million-$0.36-$0.372.7%
2014-06-302014-08-11$1.5 million-$0.43-$0.5217.31%
2014-03-312014-05-12$1.56 million-$0.64-$0.49-30.61%
2013-12-312014-03-28$425000-$0.54-$0.47-14.89%
2013-09-302013-11-12$1.11 million-$0.29

ADMA Biologics, Inc (ADMA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

ADMA Biologics, Inc (ADMA) Chart:

ADMA Biologics, Inc (ADMA) News:

Below you will find a list of latest news for ADMA Biologics, Inc (ADMA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ADMA Biologics, Inc (ADMA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-01-1630CALL0 1690.38TRUE00
2026-01-16510.42CALL0 106607.63TRUE00
2026-01-16811.89CALL0 107366.05TRUE00
2026-01-1690CALL0 0318.05TRUE00
2026-01-161010.1CALL0 36275.07TRUE00
2026-01-16118.94CALL0 1236.01TRUE00
2026-01-16127.15CALL0 230TRUE00
2026-01-16135.56CALL0 190TRUE00
2026-01-16144.6CALL0 33186.85TRUE00
2026-01-16153.6CALL0 1475139.6TRUE00
2026-01-16162.15CALL8 488795.25TRUE2.150
2026-01-16171.55CALL0 22363.94TRUE00
2026-01-16181CALL91 619111.02FALSE10
2026-01-16190.5CALL33 165098.37FALSE-0.1-0.17
2026-01-16200.2CALL1080 578288.92FALSE-0.09-0.31
2026-01-16210.1CALL11 99992.33FALSE-0.02-0.17
2026-01-16220.09CALL7 1570108.81FALSE0.090
2026-01-16230.03CALL1 233101.98FALSE0.030
2026-01-16240.05CALL0 254126.72FALSE00
2026-01-16250.01CALL0 1541188.45FALSE00
2026-01-16260.1CALL0 132226.56FALSE00
2026-01-16270.03CALL0 490166.23FALSE00
2026-01-16280.05CALL0 86178.01FALSE00
2026-01-16291.05CALL0 20213.39FALSE00
2026-01-16300.08CALL0 7233199.9FALSE00
2026-01-16310.37CALL0 55381.16FALSE00
2026-01-16320.4CALL0 9246.51FALSE00
2026-01-16330.05CALL0 48256.62FALSE00
2026-01-16340CALL0 1266.33FALSE00
2026-01-16350.01CALL0 3546247.03FALSE00
2026-01-16360CALL0 0635.11FALSE00
2026-01-16370CALL0 0597.77FALSE00
2026-01-16380.05CALL0 1685659.09FALSE00
2026-01-1630PUT0 00FALSE00
2026-01-1650PUT0 01124.13FALSE00
2026-01-1680.75PUT0 17888.46FALSE00
2026-01-1690PUT0 0742.27FALSE00
2026-01-16100.03PUT0 15667.85FALSE00
2026-01-16110PUT0 0609.74FALSE00
2026-01-16120.06PUT0 1108435.05FALSE00
2026-01-16130.04PUT0 2835187.1FALSE00
2026-01-16140.07PUT0 983165.93FALSE00
2026-01-16150.45PUT27 3067113.83FALSE0.32
2026-01-16160.27PUT1312 1916108.84FALSE0.070.35
2026-01-16170.6PUT5016 1542112.91FALSE0.220.58
2026-01-16181.05PUT1016 2166112.12TRUE0.20.24
2026-01-16191.5PUT1000 106693.67TRUE1.50
2026-01-16202.3PUT2 130098.21TRUE2.30
2026-01-16212.68PUT0 690TRUE00
2026-01-16222.9PUT0 93205.68TRUE00
2026-01-16236.5PUT0 0132.06TRUE00
2026-01-16248.8PUT0 120TRUE00
2026-01-16255.8PUT0 00TRUE00
2026-01-162610PUT0 00TRUE00
2026-01-16270PUT0 40TRUE00
2026-01-16280PUT0 00TRUE00
2026-01-16290PUT0 0249.36TRUE00
2026-01-16300PUT0 00TRUE00
2026-01-16310PUT0 00TRUE00
2026-01-16320PUT0 00TRUE00
2026-01-16330PUT0 00TRUE00
2026-01-16340PUT0 00TRUE00
2026-01-16350PUT0 00TRUE00
2026-01-16360PUT0 0311.09TRUE00
2026-01-16370PUT0 00TRUE00
2026-01-16380PUT0 00TRUE00
2026-02-20514.05CALL0 4207TRUE00
2026-02-2090CALL0 0113.11TRUE00
2026-02-20109.47CALL0 496.62TRUE00
2026-02-20118.18CALL0 657.03TRUE00
2026-02-20128.06CALL0 32117.9TRUE00
2026-02-20135.67CALL0 70TRUE00
2026-02-20144.5CALL0 1376.2TRUE00
2026-02-20153.78CALL0 13762.8TRUE00
2026-02-20163.5CALL0 3557.57TRUE00
2026-02-20172.6CALL0 8955.91TRUE00
2026-02-20181.45CALL0 19352.71FALSE00
2026-02-20191.24CALL0 20356.14FALSE00
2026-02-20200.72CALL1 26559.53FALSE0.020.03
2026-02-20210.25CALL606 23445.82FALSE-0.2-0.44
2026-02-20220.35CALL0 17579.9FALSE00
2026-02-20230.55CALL0 24110.96FALSE00
2026-02-20240.2CALL0 6865.12FALSE00
2026-02-20250.09CALL0 501128.07FALSE00
2026-02-20260.35CALL0 1135.72FALSE00
2026-02-20270CALL0 0152.68FALSE00
2026-02-20300CALL0 0162FALSE00
2026-02-20350.2CALL0 8188.1FALSE00
2026-02-2050PUT0 0453.78FALSE00
2026-02-2090.3PUT0 1267.56FALSE00
2026-02-20100.21PUT0 5264.2FALSE00
2026-02-20110.55PUT0 8198.31FALSE00
2026-02-20120.03PUT0 44184.22FALSE00
2026-02-20130.11PUT0 26172.15FALSE00
2026-02-20140.23PUT0 9059.08FALSE00
2026-02-20150.35PUT0 10268.42FALSE00
2026-02-20160.4PUT0 17951.52FALSE00
2026-02-20170.96PUT2 2660.53FALSE0.960
2026-02-20181.35PUT1 9156.67TRUE1.350
2026-02-20191.95PUT0 3949.55TRUE00
2026-02-20204.7PUT0 352.59TRUE00
2026-02-20213.1PUT0 251.41TRUE00
2026-02-20220PUT0 042.55TRUE00
2026-02-20230PUT0 059.46TRUE00
2026-02-20248.1PUT0 061.77TRUE00
2026-02-20250PUT0 068.13TRUE00
2026-02-20260PUT0 00TRUE00
2026-02-20270PUT0 00TRUE00
2026-02-20300PUT0 00TRUE00
2026-02-20350PUT0 00TRUE00
2026-03-2050CALL0 0154.52TRUE00
2026-03-20910.23CALL0 13102.02TRUE00
2026-03-20104.84CALL0 394.37TRUE00
2026-03-20115.03CALL0 1374.63TRUE00
2026-03-20125.1CALL0 3188.99TRUE00
2026-03-20135.72CALL0 478.58TRUE00
2026-03-20144.7CALL0 30775.99TRUE00
2026-03-20153.79CALL9 7766.45TRUE3.790
2026-03-20163.7CALL0 25868.57TRUE00
2026-03-20173.15CALL0 31367.15TRUE00
2026-03-20182.52CALL0 14055.23FALSE00
2026-03-20191.94CALL0 6074.09FALSE00
2026-03-20201.28CALL5 30664.25FALSE-0.04-0.03
2026-03-20211.5CALL0 11366.7FALSE00
2026-03-20220.79CALL25 44764.56FALSE0.790
2026-03-20230.95CALL0 13057.51FALSE00
2026-03-20240.76CALL0 48893.75FALSE00
2026-03-20250.37CALL0 103398.28FALSE00
2026-03-20270.48CALL0 9111.64FALSE00
2026-03-20300.16CALL0 1189.33FALSE00
2026-03-20350.5CALL0 1135.93FALSE00
2026-03-2050PUT0 0303.08FALSE00
2026-03-2090PUT0 0193.04FALSE00
2026-03-20100PUT0 0170.65FALSE00
2026-03-20110PUT0 0150.53FALSE00
2026-03-20120.23PUT0 209110.05FALSE00
2026-03-20130.36PUT47 45172.19FALSE0.030.09
2026-03-20140.49PUT0 46486.59FALSE00
2026-03-20150.8PUT1 32469.14FALSE0.130.19
2026-03-20161.1PUT6 30366.96FALSE0.10.1
2026-03-20171.38PUT0 5762.43FALSE00
2026-03-20181.95PUT24 2163.87TRUE-0.1-0.05
2026-03-20192.25PUT0 7564.29TRUE00
2026-03-20203.1PUT0 559TRUE00
2026-03-20210PUT0 061.41TRUE00
2026-03-20220PUT0 053.87TRUE00
2026-03-20230PUT0 067.14TRUE00
2026-03-20240PUT0 059.43TRUE00
2026-03-20250PUT0 061.99TRUE00
2026-03-20270PUT0 059.37TRUE00
2026-03-20300PUT0 00TRUE00
2026-03-20350PUT0 00TRUE00
2026-04-17510.48CALL0 13153.15TRUE00
2026-04-1796.9CALL0 995.52TRUE00
2026-04-17108.34CALL0 1091.35TRUE00
2026-04-17110CALL0 00TRUE00
2026-04-17120CALL0 079.38TRUE00
2026-04-17136.19CALL0 2577.16TRUE00
2026-04-17144.92CALL0 2171.21TRUE00
2026-04-17153.73CALL0 3366.25TRUE00
2026-04-17163.46CALL23 12165.23TRUE3.460
2026-04-17172.92CALL5 1365.2TRUE2.920
2026-04-17183.12CALL0 4659.7FALSE00
2026-04-17192.72CALL0 13174.18FALSE00
2026-04-17201.55CALL25 4161.17FALSE-0.84-0.35
2026-04-17212.05CALL0 1156.57FALSE00
2026-04-17221.1CALL1 3463.55FALSE1.10
2026-04-17231CALL0 3156.27FALSE00
2026-04-17240.9CALL0 1870.89FALSE00
2026-04-17251.15CALL0 32107.69FALSE00
2026-04-17270.34CALL0 198.58FALSE00
2026-04-17300.32CALL0 1104.69FALSE00
2026-04-17350CALL0 0121.7FALSE00
2026-04-1750PUT0 0375.58FALSE00
2026-04-1790PUT0 0224.78FALSE00
2026-04-17100.5PUT0 1000144.35FALSE00
2026-04-17110.37PUT0 34127.39FALSE00
2026-04-17120.3PUT13 52068.01FALSE00
2026-04-17130.47PUT6 18667.11FALSE0.020.04
2026-04-17140.6PUT0 9567.41FALSE00
2026-04-17150.89PUT2 8861.98FALSE0.110.14
2026-04-17161.3PUT6 8663.25FALSE00
2026-04-17171.61PUT0 6362.56FALSE00
2026-04-17182.37PUT0 2072.37TRUE00
2026-04-17192.75PUT1 660.34TRUE2.750
2026-04-17202.5PUT0 1654.76TRUE00
2026-04-17210PUT0 051.21TRUE00
2026-04-17220PUT0 062.76TRUE00
2026-04-17234.2PUT0 350.51TRUE00
2026-04-17240PUT0 049.19TRUE00
2026-04-17256.6PUT0 548.18TRUE00
2026-04-17270PUT0 059.55TRUE00
2026-04-17300PUT0 00TRUE00
2026-04-17350PUT0 00TRUE00
2026-05-1550CALL0 0132.55TRUE00
2026-05-1580CALL0 095.15TRUE00
2026-05-1590CALL0 091.14TRUE00
2026-05-15105.18CALL0 760TRUE00
2026-05-15115CALL0 279.9TRUE00
2026-05-15120CALL0 080.45TRUE00
2026-05-15134.6CALL0 172.92TRUE00
2026-05-15140CALL0 067.04TRUE00
2026-05-15154.62CALL0 1269.75TRUE00
2026-05-15164.4CALL0 8664.74TRUE00
2026-05-15173.6CALL0 1763.97TRUE00
2026-05-15182.96CALL0 6365.44FALSE00
2026-05-15192.7CALL0 2476.86FALSE00
2026-05-15201.9CALL3 4861.87FALSE-0.2-0.1
2026-05-15212.5CALL0 1770.97FALSE00
2026-05-15221.85CALL0 3275.68FALSE00
2026-05-15231.1CALL1 1661.19FALSE1.10
2026-05-15241.65CALL0 3574.3FALSE00
2026-05-15250.66CALL0 2085.67FALSE00
2026-05-15300.65CALL0 291.94FALSE00
2026-05-15350.21CALL0 293.52FALSE00
2026-05-1550PUT0 0207.36FALSE00
2026-05-1580PUT0 0138.64FALSE00
2026-05-1590PUT0 0122.23FALSE00
2026-05-15100PUT0 0127.56FALSE00
2026-05-15110.54PUT0 30112.61FALSE00
2026-05-15120.7PUT0 8108.65FALSE00
2026-05-15131.1PUT0 4102.15FALSE00
2026-05-15140.8PUT0 1589FALSE00
2026-05-15151.15PUT0 2366.83FALSE00
2026-05-15161.5PUT0 2265.09FALSE00
2026-05-15171.94PUT0 3261.97FALSE00
2026-05-15184.6PUT0 165.55TRUE00
2026-05-15192.8PUT0 1063.35TRUE00
2026-05-15203.2PUT0 757.46TRUE00
2026-05-15213.7PUT0 158.7TRUE00
2026-05-15224.2PUT0 254.84TRUE00
2026-05-15235PUT0 148.86TRUE00
2026-05-15240PUT0 052.08TRUE00
2026-05-15250PUT0 056.57TRUE00
2026-05-15300PUT0 00TRUE00
2026-05-15350PUT0 00TRUE00
2026-06-18511.33CALL0 44130.55TRUE00
2026-06-1897.91CALL0 10182.6TRUE00
2026-06-18100CALL0 090.82TRUE00
2026-06-18114.88CALL0 1076.65TRUE00
2026-06-18126.7CALL0 1281.61TRUE00
2026-06-18135.87CALL0 268.76TRUE00
2026-06-18147.32CALL0 866.04TRUE00
2026-06-18154.58CALL0 18163.69TRUE00
2026-06-18165.73CALL0 163.97TRUE00
2026-06-18174.25CALL0 866.29TRUE00
2026-06-18183.7CALL0 123068.34FALSE00
2026-06-18193.4CALL1 1378.89FALSE3.40
2026-06-18202.75CALL25 38672.39FALSE0.150.06
2026-06-18221.47CALL8 21257.29FALSE1.470
2026-06-18250.75CALL0 25100.79FALSE00
2026-06-18270.7CALL0 40973.94FALSE00
2026-06-18300.37CALL0 1581.21FALSE00
2026-06-18350.1CALL0 3088.83FALSE00
2026-06-1850PUT0 0294.66FALSE00
2026-06-1890.46PUT0 8176.58FALSE00
2026-06-18100PUT0 0111.41FALSE00
2026-06-18110.3PUT0 1082.02FALSE00
2026-06-18120.25PUT0 1060.99FALSE00
2026-06-18130.8PUT2 1665.29FALSE0.80
2026-06-18141.1PUT1 564.93FALSE1.10
2026-06-18151.3PUT0 2464.36FALSE00
2026-06-18161.7PUT0 183.52FALSE00
2026-06-18170PUT0 063.42FALSE00
2026-06-18183.7PUT0 1165.25TRUE00
2026-06-18192.65PUT0 1067.49TRUE00
2026-06-18203.7PUT0 3364.47TRUE00
2026-06-18220PUT0 058.73TRUE00
2026-06-18256.35PUT0 251.4TRUE00
2026-06-18270PUT0 00TRUE00
2026-06-18300PUT0 060.86TRUE00
2026-06-18350PUT0 00TRUE00
2026-08-21100CALL0 072.59TRUE00
2026-08-21110CALL0 066.69TRUE00
2026-08-21120CALL0 067.37TRUE00
2026-08-21130CALL0 066.4TRUE00
2026-08-21140CALL0 064.37TRUE00
2026-08-21150CALL0 068.18TRUE00
2026-08-21164.8CALL0 465.29TRUE00
2026-08-21170CALL0 069.58TRUE00
2026-08-21180CALL0 066.63FALSE00
2026-08-21190CALL0 065.87FALSE00
2026-08-21202.65CALL5 11558.63FALSE2.650
2026-08-21212.35CALL0 263.32FALSE00
2026-08-21220CALL0 062.04FALSE00
2026-08-21230CALL0 061.55FALSE00
2026-08-21240CALL0 052.32FALSE00
2026-08-21251.23CALL0 671.78FALSE00
2026-08-21260CALL0 089.98FALSE00
2026-08-21271.2CALL0 291.56FALSE00
2026-08-21301.25CALL2 370.31FALSE1.250
2026-08-21100PUT0 0131.91FALSE00
2026-08-21110PUT0 085.29FALSE00
2026-08-21120.8PUT0 167.43FALSE00
2026-08-21131.05PUT6 262.85FALSE1.050
2026-08-21140PUT0 065.31FALSE00
2026-08-21151.3PUT0 554.47FALSE00
2026-08-21162.5PUT0 164.21FALSE00
2026-08-21170PUT0 061.11FALSE00
2026-08-21180PUT0 057.85TRUE00
2026-08-21194.7PUT0 153.46TRUE00
2026-08-21200PUT0 056.41TRUE00
2026-08-21210PUT0 051.34TRUE00
2026-08-21220PUT0 049.93TRUE00
2026-08-21230PUT0 052.57TRUE00
2026-08-21240PUT0 050.65TRUE00
2026-08-21250PUT0 048.8TRUE00
2026-08-21260PUT0 045.71TRUE00
2026-08-21270PUT0 039.33TRUE00
2026-08-21300PUT0 00TRUE00
2027-01-15311.92CALL0 330TRUE00
2027-01-15514.96CALL0 11102.77TRUE00
2027-01-1589.28CALL0 2773.3TRUE00
2027-01-15109.15CALL23 42967.71TRUE-0.05-0.01
2027-01-15137.3CALL0 8470.96TRUE00
2027-01-15156CALL0 67069.19TRUE00
2027-01-15175.75CALL0 26174.88TRUE00
2027-01-15203.53CALL0 71369.6FALSE00
2027-01-15223.3CALL0 38059.93FALSE00
2027-01-15253.5CALL2 64874.41FALSE1.130.48
2027-01-15271.8CALL0 344054.61FALSE00
2027-01-15301.4CALL0 57360.24FALSE00
2027-01-15320.55CALL0 2287.03FALSE00
2027-01-15350.5CALL0 15883.2FALSE00
2027-01-15370.9CALL0 493.03FALSE00
2027-01-1530PUT0 0391.78FALSE00
2027-01-1550PUT0 5223.96FALSE00
2027-01-1580.52PUT0 7114.93FALSE00
2027-01-15101.21PUT0 45124.28FALSE00
2027-01-15131.69PUT0 102459.34FALSE00
2027-01-15152.81PUT0 12662.43FALSE00
2027-01-15173.1PUT0 9860.26FALSE00
2027-01-15205.23PUT0 4265.99TRUE00
2027-01-15225.5PUT0 19653.01TRUE00
2027-01-15258PUT0 4751.14TRUE00
2027-01-15270PUT0 341.95TRUE00
2027-01-15300PUT0 045.18TRUE00
2027-01-15320PUT0 043.88TRUE00
2027-01-15350PUT0 00TRUE00
2027-01-153717.31PUT0 00TRUE00
2028-01-21312.42CALL0 4197.25TRUE00
2028-01-2150CALL0 062.15TRUE00
2028-01-21813.1CALL0 367.25TRUE00
2028-01-211010.1CALL0 2981.75TRUE00
2028-01-21138.9CALL0 8676.49TRUE00
2028-01-21158.05CALL0 12560.28TRUE00
2028-01-21178.2CALL0 2157.69TRUE00
2028-01-21205.6CALL0 37860.9FALSE00
2028-01-21224.7CALL0 13669.71FALSE00
2028-01-21254.5CALL0 15666FALSE00
2028-01-21272.84CALL0 1554.72FALSE00
2028-01-21303.53CALL0 1254.93FALSE00
2028-01-21352.1CALL0 1155.22FALSE00
2028-01-2130PUT0 00FALSE00
2028-01-2150PUT0 00FALSE00
2028-01-2181.07PUT0 263.98FALSE00
2028-01-21101.66PUT0 190.68FALSE00
2028-01-21132.15PUT0 268.9FALSE00
2028-01-21153.3PUT0 1766.21FALSE00
2028-01-21174.3PUT0 1457.34FALSE00
2028-01-21200PUT0 058.75TRUE00
2028-01-21220PUT0 055.06TRUE00
2028-01-21250PUT0 053.19TRUE00
2028-01-21270PUT0 052.7TRUE00
2028-01-21300PUT0 053.38TRUE00
2028-01-21350PUT0 049.02TRUE00

Latest ADMA Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST38$1.905
Jun 13, 2022 7:59 PM EST100$1.905
Jun 13, 2022 7:59 PM EST100$1.905
Jun 13, 2022 7:59 PM EST36$1.905
Jun 13, 2022 7:59 PM EST100$1.9

ADMA Biologics, Inc (ADMA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000713/0001193805-20-000713-index.htm
2019-10-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1368514/000000000019014431/0000000000-19-014431-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000083423720008032/0000834237-20-008032-index.htm
2020-03-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000083423720009209/0000834237-20-009209-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924319014466/0000899243-19-014466-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924320003914/0000899243-20-003914-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924320009225/0000899243-20-009225-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000091957419001192/0000919574-19-001192-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000091957420001141/0000919574-20-001141-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000108514619000734/0001085146-19-000734-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000108514620000752/0001085146-20-000752-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000112329219000868/0001123292-19-000868-index.htm
2019-06-07SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1368514/000112329219000869/0001123292-19-000869-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000114036120010160/0001140361-20-010160-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1368514/000114036120010161/0001140361-20-010161-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312519040961/0001193125-19-040961-index.htm
2019-05-23SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312519154707/0001193125-19-154707-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312520038101/0001193125-20-038101-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001175/0001193805-18-001175-index.htm
2018-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001198/0001193805-18-001198-index.htm
2018-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001210/0001193805-18-001210-index.htm
2018-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001238/0001193805-18-001238-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001316/0001193805-18-001316-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380518001319/0001193805-18-001319-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001425/0001193805-18-001425-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001429/0001193805-18-001429-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001431/0001193805-18-001431-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000012/0001193805-19-000012-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000026/0001193805-19-000026-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000090/0001193805-19-000090-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000091/0001193805-19-000091-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000092/0001193805-19-000092-index.htm
2019-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000098/0001193805-19-000098-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000160/0001193805-19-000160-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000246/0001193805-19-000246-index.htm
2019-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000251/0001193805-19-000251-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000254/0001193805-19-000254-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000280/0001193805-19-000280-index.htm
2019-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000281/0001193805-19-000281-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000292/0001193805-19-000292-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000293/0001193805-19-000293-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000294/0001193805-19-000294-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000295/0001193805-19-000295-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000296/0001193805-19-000296-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000297/0001193805-19-000297-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000301/0001193805-19-000301-index.htm
2019-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000332/0001193805-19-000332-index.htm
2019-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000339/0001193805-19-000339-index.htm
2019-04-05PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000346/0001193805-19-000346-index.htm
2019-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000366/0001193805-19-000366-index.htm
2019-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000415/0001193805-19-000415-index.htm
2019-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000441/0001193805-19-000441-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000454/0001193805-19-000454-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000455/0001193805-19-000455-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000470/0001193805-19-000470-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000490/0001193805-19-000490-index.htm
2019-05-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000492/0001193805-19-000492-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000496/0001193805-19-000496-index.htm
2019-05-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000498/0001193805-19-000498-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000521/0001193805-19-000521-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/0001193805-19-000522-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/0001193805-19-000523-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/0001193805-19-000524-index.htm
2019-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000525/0001193805-19-000525-index.htm
2019-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000540/0001193805-19-000540-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000559/0001193805-19-000559-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000561/0001193805-19-000561-index.htm
2019-06-128-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000569/0001193805-19-000569-index.htm
2019-07-01PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000614/0001193805-19-000614-index.htm
2019-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000621/0001193805-19-000621-index.htm
2019-07-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000637/0001193805-19-000637-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000714/0001193805-19-000714-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000715/0001193805-19-000715-index.htm
2019-08-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000761/0001193805-19-000761-index.htm
2019-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000774/0001193805-19-000774-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000798/0001193805-19-000798-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000839/0001193805-19-000839-index.htm
2019-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000887/0001193805-19-000887-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000893/0001193805-19-000893-index.htm
2019-10-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1368514/000119380519000903/0001193805-19-000903-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000905/0001193805-19-000905-index.htm
2019-10-07424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000907/0001193805-19-000907-index.htm
2019-10-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001327/0001193805-19-001327-index.htm
2019-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001351/0001193805-19-001351-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001355/0001193805-19-001355-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001361/0001193805-19-001361-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001396/0001193805-19-001396-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519001398/0001193805-19-001398-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001423/0001193805-19-001423-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001461/0001193805-19-001461-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001941/0001193805-19-001941-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000010/0001193805-20-000010-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000024/0001193805-20-000024-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000033/0001193805-20-000033-index.htm
2020-02-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000106/0001193805-20-000106-index.htm
2020-02-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000109/0001193805-20-000109-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000110/0001193805-20-000110-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000129/0001193805-20-000129-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/0001193805-20-000133-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/0001193805-20-000135-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000138/0001193805-20-000138-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000139/0001193805-20-000139-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000259/0001193805-20-000259-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/0001193805-20-000285-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000286/0001193805-20-000286-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000287/0001193805-20-000287-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/0001193805-20-000288-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/0001193805-20-000289-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000290/0001193805-20-000290-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000291/0001193805-20-000291-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000292/0001193805-20-000292-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000293/0001193805-20-000293-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000300/0001193805-20-000300-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000348/0001193805-20-000348-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000349/0001193805-20-000349-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000377/0001193805-20-000377-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000452/0001193805-20-000452-index.htm
2020-04-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000474/0001193805-20-000474-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000502/0001193805-20-000502-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000529/0001193805-20-000529-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000548/0001193805-20-000548-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000549/0001193805-20-000549-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000550/0001193805-20-000550-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000551/0001193805-20-000551-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000552/0001193805-20-000552-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000553/0001193805-20-000553-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000561/0001193805-20-000561-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000562/0001193805-20-000562-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000618/0001193805-20-000618-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000638/0001193805-20-000638-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000710/0001193805-20-000710-index.htm
2020-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000712/0001193805-20-000712-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000713/0001193805-20-000713-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000770/0001193805-20-000770-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000957/0001193805-20-000957-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000960/0001193805-20-000960-index.htm
2020-08-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000961/0001193805-20-000961-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001004/0001193805-20-001004-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001036/0001193805-20-001036-index.htm
2020-08-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001111/0001193805-20-001111-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001128/0001193805-20-001128-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/0001193805-20-001129-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/0001193805-20-001135-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001139/0001193805-20-001139-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001390/0001193805-20-001390-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520001392/0001193805-20-001392-index.htm
2020-11-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520001393/0001193805-20-001393-index.htm
2019-10-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1368514/999999999519002318/9999999995-19-002318-index.htm
2018-09-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1368514/999999999718008174/9999999997-18-008174-index.htm
2019-04-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1368514/999999999719002962/9999999997-19-002962-index.htm
2020-02-03SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1368514/999999999720000431/9999999997-20-000431-index.htm
2020-02-10SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1368514/999999999720000623/9999999997-20-000623-index.htm

ADMA Biologics, Inc (ADMA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ADMA Biologics, Inc (ADMA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 213%
Institutional Ownership: 5451%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-05-17Jerrold B GrossmanDirectorBuy12,000.004.0048,000.00110,007.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/0001193805-19-000524-index.htm
2019-05-21PERCEPTIVE ADVISORS LLC10% Share HolderBuy4,000,000.004.0016,000,000.0011,521,102.00https://www.sec.gov/Archives/edgar/data/1368514/000089924319014466/0000899243-19-014466-index.htm
2020-02-11Jerrold B GrossmanDirectorBuy22,857.003.5079,999.50132,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2020-02-28Jerrold B GrossmanDirectorBuy7,500.00140,364.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/0001193805-20-000288-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy200.002.87574.00140,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy5,000.002.8914,450.00145,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy5,000.002.9014,475.00150,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-21Jerrold B GrossmanDirectorBuy5,000.002.5612,800.00155,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-08-21Jerrold B GrossmanDirectorBuy300.002.62786.00155,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-02-11PERCEPTIVE ADVISORS LLC10% Share HolderBuy4,563,700.003.5015,972,950.0016,084,802.00https://www.sec.gov/Archives/edgar/data/1368514/000089924320003914/0000899243-20-003914-index.htm
2020-09-10Jerrold B GrossmanDirectorBuy5,000.002.2211,100.00160,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/0001193805-20-001135-index.htm
2020-03-19PERCEPTIVE ADVISORS LLC10% Share HolderBuy500,000.002.101,050,000.0016,584,802.00https://www.sec.gov/Archives/edgar/data/1368514/000089924320009225/0000899243-20-009225-index.htm
2020-02-28Adam S GrossmanPresident and CEOBuy100,000.00166,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000287/0001193805-20-000287-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy10.003.0630.60166,108.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy2,990.003.079,179.30169,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy2,000.003.046,080.00171,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-11Adam S GrossmanPresident and CEOBuy1,000.002.972,970.00172,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-09-08Adam S GrossmanPresident and CEOBuy4,000.002.248,959.60176,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001128/0001193805-20-001128-index.htm
2019-05-17James MondEVP, CSO and CMOBuy4,500.004.0018,000.0017,889.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/0001193805-19-000522-index.htm
2020-08-13MARTHA J DEMSKIDirectorBuy2,000.002.885,760.002,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001036/0001193805-20-001036-index.htm
2020-02-11James MondCSO and CMOBuy4,285.003.5014,997.5022,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/0001193805-20-000133-index.htm
2020-02-11Jerrold B GrossmanDirectorBuy22,857.003.5079,999.5022,857.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2019-05-17BRIAN LENZEVP, CFOBuy5,000.004.0020,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000521/0001193805-19-000521-index.htm
2020-02-11BRIAN LENZEVP, CFOBuy7,142.003.5024,997.0032,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000129/0001193805-20-000129-index.htm
2019-05-17Adam S GrossmanPresident and CEOBuy5,000.004.0020,000.0037,527.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2020-09-11MARTHA J DEMSKIDirectorBuy2,200.002.295,038.004,200.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001139/0001193805-20-001139-index.htm
2019-06-06Biotest Divestiture Trust10% Share HolderSell5,813,954.003.7521,802,327.504,295,580.00https://www.sec.gov/Archives/edgar/data/1368514/000112329219000868/0001123292-19-000868-index.htm
2020-02-28ERIC I RICHMANDirectorBuy7,500.0044,030.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000290/0001193805-20-000290-index.htm
2019-05-17Lawrence P. GuiheenDirectorBuy25,000.004.00100,000.0050,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/0001193805-19-000523-index.htm
2020-02-28James MondEVP, CSO and CMOBuy40,000.0062,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/0001193805-20-000285-index.htm
2020-02-11Adam S GrossmanPresident and CEOBuy28,571.003.5099,998.5066,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm
2020-08-10James MondEVP, CSO and CMOBuy5,000.002.8814,400.0067,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-08-10James MondEVP, CSO and CMOBuy2,000.002.885,750.0069,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-02-11Lawrence P. GuiheenDirectorBuy20,000.003.5070,000.0070,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/0001193805-20-000135-index.htm
2020-02-28BRIAN LENZEVP, CFOBuy40,000.0072,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000286/0001193805-20-000286-index.htm
2020-09-08James MondEVP, CSO and CMOBuy4,000.002.208,800.0073,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/0001193805-20-001129-index.htm
2020-02-28Bryant FongDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000293/0001193805-20-000293-index.htm
2020-02-28DOV A MD GOLDSTEINDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000291/0001193805-20-000291-index.htm
2020-02-28STEVE ELMSDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000292/0001193805-20-000292-index.htm
2020-08-11BRIAN LENZEVP, CFOBuy4,000.002.9711,860.0076,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001004/0001193805-20-001004-index.htm
2020-02-28Lawrence P. GuiheenDirectorBuy7,500.0077,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/0001193805-20-000289-index.htm
2019-05-17Adam S GrossmanPresident and CEOBuy25,000.004.00100,000.00821,301.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2020-02-11Adam S GrossmanPresident and CEOBuy57,143.003.50200,000.50878,444.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm